Amphenol Corp. (NYSE:APH) stock tumbled Wednesday after the company reported fourth-quarter and full-year 2025 results.
Sales of $6.43 billion rose 49% in U.S. dollars and 37% organically year over year, beating the consensus of $6.18 billion.
Adjusted diluted EPS came in at 97 cents, up 76% year over year, beating the consensus of 93 cents.
Adjusted operating margin for the quarter was 27.5%.
Amphenol exited the quarter with $11.13 billion in cash and cash equivalents.
During the fourth quarter, the company purchased 1.3 million shares of its common stock for $171 million and paid dividends of $202 million, resulting in total capital returned to shareholders of nearly $1.5 billion in 2025.
“Sales in the fourth quarter and for the full year increased from the prior year by 49% and 52%, respectively, driven by strong organic growth in virtually all of our end markets, including exceptional organic growth in the IT datacom market, as well as contributions from the company’s acquisition program,” said President and CEO R. Adam Norwitt. “For both the quarter and full year, we once again realized excellent profitability, with adjusted operating margins reaching 27.5% and 26.2%, respectively.”
Outlook
For the first quarter of 2026, Amphenol expects sales in the range of $6.90 billion to $7.00 billion, representing a 43% to 45% increase over the prior-year quarter.
Adjusted diluted EPS is expected to be between 91 cents and 93 cents, representing a 44% to 48% increase year over year. The guidance includes approximately $900 million in sales and 2 cents in adjusted diluted EPS accretion from the CCS business.
On Tuesday, JP Morgan analyst Samik Chatterjee maintained Amphenol with an Overweight rating and raised the price target from $160 to $185.
APH Price Action: Amphenol shares were down 14.78% at $141.66 at the time of publication on Wednesday, according to Benzinga Pro data.
Photo via Shutterstock
Recent Comments